Improved Care for Acute Myocardial Infarction Linking Referral and Receiving Centres – How can We Communicate Better? Dr. James McMeekin AMI Faculty Cardiologist,

Slides:



Advertisements
Similar presentations
ACTION Registry (Acute Coronary Treatment and Intervention Outcomes Network) Initial Report 1st Quarter 2007 Results Report prepared by: www. ncdr.com.
Advertisements

New Atrial Fibrillation/Flutter Pathway and GRASP Tool
BASE HOSPITAL GROUP ONTARIO Chapter 3 for 12 Lead Training -WHY 12 LEAD- Ontario Base Hospital Group Education Subcommittee 2008 TIME IS MUSCLE.
Chapter 3 for 12 Lead Training -Precourse-
Presented by: Fahim H. Jafary, M.D., F.A.C.C. Associate Professor of Medicine Aga Khan University Hospital, Karachi March 14, 2008 Primary Percutaneous.
A Pharmaco-invasive Reperfusion Strategy with Immediate Percutaneous Coronary Intervention is Safe and Effective in ST-Elevation Myocardial Infarction.
CABG VS Multi Vessel PCI Hasanat Sharif MD FRCS Chief of Cardiorthoracic Surgery Aga Khan University Hospital.
Regional Systems of Care to Optimize Timeliness of Reperfusion Therapy for STEMI: The Mayo Clinic Protocol Henry H. Ting, MD, MBA Associate Professor of.
Bree Collaborative Cardiology Report: Appropriateness of Percutaneous Cardiac Interventions (PCI) Bree Collaborative Meeting November 30, 2012.
Current and Future Perspectives on Acute Coronary Syndromes Paul W. Armstrong MD AMI Quebec Montreal October 1, 2010.
An Immediate Nursing Feedback Program for Primary PCI for ST-segment Elevation Myocardial Infarction Karen Mckenny RN, Theresa Fortner RN, Cheryl McNeil.
STEMI: What’s the Rush? STEMI: What’s the Rush? William Phillips, MD, FACC, FSCAI Director of Cardiology CMMC A PCI Center perspective.
Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: complete revascularization versus conservative strategy. PRAGUE 13 trial O.
Acute Coronary Syndromes Clinical Care Standard An introduction for clinicians and health services.
Development of Clinical Pathways to Streamline Care for Patients Presenting with Suspected Cardiac Chest Pain Background The National Heart Foundation.
Very Rapid Treatment of STEMI: Utilizing Pre-Hospital ECGs to Bypass the Emergency Department Kenneth W. Baran, MD Medical Director for United Hospital’s.
Clinical Trial Results. org Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention.
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
Masoudi FA et al J Am Coll Cardiol (Published online 27 November 2008) CVN Weekly Interventional Update December 8, 2008 Jeffrey J. Popma and Christopher.
QI ACTION Registry-Get With The Guidelines The Mission Lifeline Data Solution Kathleen O’Neill, MHA Senior Director, Quality Initiatives IL & SD American.
Francesco Liistro Cardiovascular Department, Arezzo, Italy Impact of Thrombus Aspiration on Myocardial Tissue Reperfusion and Left Ventricular Functional.
The Heart of the Matter A Journey through the system of care.
CRUSADE: A National Quality Improvement Initiative CRUSADE: A National Quality Improvement Initiative Can Rapid Risk Stratification of Unstable Angina.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
GP IIb/IIIa Inhibition in STEMI: Growing Clinical Trial Evidence.
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
1 DIAGNOSTICS OF Acute Coronary Syndromes At the end of this self study the participant will: Verbalize meanings of specific ECG changes: –ST Elevation.
ACS and Thrombosis in the Emergency Setting
Overview of Swedish Quality Registries Bertil Lindahl, Professor in Cardiology, Director of Uppsala Clinical Research center.
Ambulance Victoria and MonashHEART Acute Myocardial Infarction (Mon-AMI) 12 lead ECG project. An update On behalf of the MonAMI Team A Hutchison, Y Malaiapan,
Role of Percutaneous coronary intervention (PCI) after thrombolytic therapy By Dr. Mohamed Mahros Assistant lecturer of cardiology Benha faculty of medicine.
California Stroke Registry Right Care Initiative Meeting August 13, 2012.
TRI vs TFI in STEMI Shenyang Northern Hospital Wang Shouli Han Yalin.
Critical Appraisal Did the study address a clearly focused question? Did the study address a clearly focused question? Was the assignment of patients.
National AMI Information Call February 5, 2008 Patient Safety Initiative.
Athens Cardiology Update CADILLAC Study Blood Transfusion after Myocardial Infarction: Friend, Foe or double-edged Sword? Georgios I. Papaioannou,
Which Early ST-Elevation Myocardial Infarction Therapy (WEST) Trial Paul W. Armstrong, WEST Steering Committee Published in The European Heart Journal.
Myocardial Ischaemia National Audit Project Are we replacing good fibrinolytic treatment with poor primary PCI? John Birkhead who has NO CONFLICT OF INTEREST.
UNIVERSITÄT LEIPZIG H E R Z Z E N T R U M Infarct transmurality and infarct size assessed by delayed enhancement magnetic resonance imaging: Association.
Acute Coronary Syndromes SIGN 93. MINAP Mortality after Acute Coronary Syndromes Cumulative: 13.6% Blue 10.6% Green 11.6% Red.
The Health Roundtable Saving heart muscle by reducing delays to getting patients to the overnight regional catheter lab Presenter: Debby Hailstone Middlemore.
ST ELEVATION MYOCARDIAL INFARCTION (STEMI) PATIENT DISCHARGE INSTRUCTION CHECKLIST: CAN WE DO BETTER? Maryann Rabusic-Wiedener, Shauna Johns, Tina Ainsworth,
Inter-Hospital Transfer of High Risk STEMI Patients for PCI is Safe and Feasible David M. Larson, Katie M. Menssen, Scott W. Sharkey, Marc C. Newell, Anil.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
Acute Myocardial Infarction February 8, 2006.
Dallas 2015 TFQO: Karen Woolfrey #COI 261 EVREV 1: Karen Woolfrey # COI 261 EVREV 2: Daniel Pichel #COI 513 Taskforce: ACS ACS 872: Pre-hospital Diversion.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2007 Focused Update of the ACC/AHA 2004 Guidelines.
Randomized Early versus Late AbciXimab in Acute Myocardial Infarction treated with primary coronary intervention (RELAx-AMI Trial) Mauro Maioli M.D., Francesco.
High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
No conflicts of interest or financial ties to disclose.
Overview of the Winnipeg CODE STEMI Project Implemented May 2008 Dr.J.Tam MD, FRCP(C), FACC Section Chief Cardiology WRHA and University of Manitoba Lillian.
SPEED : GUSTO-IV PILOT GUSTO-IV Pilot Trial. SPEED : GUSTO-IV PILOT Rationale for Combination Therapy in AMI Enhance Incidence and Speed of Reperfusion.
M-Guard stent in STEMI patients with high thrombus burden lesions Mahmoud Shabestari Baktash Bayani Ali Eshraghi Bahram Shahri Mashhad University.
Telemedicine To Expedite Patient’s Transfer: The Introduction of the Videophone Lowell Satler, MD Washington Hospital Center.
A Clinical profile of patients enrolled in the Pakistan ACS registry
Optimising STEMi Care- Role of Nurses and Paramedics
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
European Heart Association Journal 2007 April
The Time Dependence of Anti-thrombin Initiation in Patients with Non-ST-segment –elevation Acute Coronary Syndrome: Subgroup Analysis form the ACUITY.
European Society of Cardiology 2003
Figure 1 PCI strategies in patients with STEMI and multivessel disease
Published in the European Heart Journal
American College of Cardiology Presented by Dr. Michel R. Le May
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
Maintenance of Long-Term Clinical Benefit with
Pre-hospital prediction of transmural myocardial infarction and the need of acute coronary reperfusion by an artificial neural network compared to real-time.
Presentation transcript:

Improved Care for Acute Myocardial Infarction Linking Referral and Receiving Centres – How can We Communicate Better? Dr. James McMeekin AMI Faculty Cardiologist, Foothills Medical Centre, Calgary Health Region

Improved Care for Acute Myocardial Infarction- Outline 1. History of the Calgary Health Region STEMI Project - a system approach 2. Changing reperfusion management in the STEMI Population 3. New directions- STEMI project in the Rural Calgary Health Region

History of the CHR STEMI Project 2003 –STEMI project (STrategic Evaluation and Management of ST Elevation MI) initiated by Cardiology Interventional group –willing to be on call 24/7 for Direct PCI for STEMI population –Approached QI Council to make it a QI project

Calgary’s STEMI initiative Goals 1. Develop a comprehensive management model for ST Elevation MI 2. Optimize the use of timely reperfusion therapy and use PCI as the primary reperfusion therapy whenever possible (60-90 minutes) 3. Initiate an early discharge program for low risk patients 4. Improve and coordinate discharge and access to out patient care/community care

1. Develop a comprehensive management model for ST Elevation MI Many players- EMS, ED, Cardiac Cath Lab, CCU Many meetings Many lessons

P = 0.02P < Optimize the use of timely reperfusion therapy

3. Initiate an early discharge program for low risk patients Develop criteria for a low risk post STEMI group for discharge on day Ensure all discharge planning is covered whether in hospital or in community Track this low risk group in AMI data base

Objectives 1. To use the Cadillac trial Risk Score to determine risk groups in our STEMI population. 2. To monitor length of stay (LOS) and complication rates in each risk group. 3. To understand reasons (clinical and operational) why patients were not discharged within the target.

The Cadillac (Controlled Abciximab Device Investigation to Lower Late Angioplasty Complications) Risk Stratification Score (J Am Coll Cardiol 2005; 45: ). Risk Factor Baseline LVEF < 40% Renal Insufficiency Killip Class ≥2 Final TIMI Flow ≤2 Age > 65 years Anemia 3 Vessel Disease Score Range: Score433222_2_0-18

Cadillac Risk Score Characteristics Risk Low Intermediate High Risk Score ≥6 1 yr mortality 12% D/C Target Clinical (Days) judgment JACC 2005;45:

Patient Characteristics 297 consecutive STEMI patients were assigned risk scores between Jan. 25, 2006 and Jan 31, Risk Low (0-2) Interm (3-5) High (>5) n Mean Age 58* 63** 68* ** Male 77% 74% 64% * **p<.05

Patient Characteristics RISK Group LOW Intermediate HIGH DM15% 22% 25% HTN39% 50% 46% Smoker41% 38% 30% Prev MI11% 9% 22% Prev PCI10% 10% 16% Prev CABG 1% 0% 3% Stroke 3% 6% 7% Killip Class ≥2 0%* 13%** 26%* ** * **p<.05

Length of Stay * ** * ** p <.05 *

In Hospital Complications excluding Death * * * p<.05

In Hospital Death * * * p <.05

30 Day Complications Including Death * * *p<.05

Percent Discharged by Target Risk Group: Low (≤3 d) Interm (≤5d) High (≥6d) 28% 50% N/A 28% 50% N/A

Low Risk Group 104/148 low risk patients were not discharged by the target of 3 days ( 72%) Of the 104 patients, the reason for delay in discharge was analyzed: clinical (65 pts) and operational issues (39 pts) were identified (system issues with potential for improvement)

Clinical Delays to Discharge n=65

Operational Delays to Discharge n=39/104 Operational Delays to Discharge n=39/104

Conclusions 1. The CRS predicts complications in the risk groups well and ability to discharge a low risk population, early after STEMI, only modestly well. 2. There are operational factors that may contribute to prolonged hospital stays. 3. Targeting these factors with improvement strategies may shorten the length of stay.

4. Improve and coordinate discharge and access to out patient care/community care –Nurse clinicians in CCU identify low risk patients through the risk score –Patient referred for follow-up and medical assessment in a Nurse run STEMI clinic 1 week after discharge –Automatic referral to Cardiac Rehabilitation program

History of the CHR STEMI Project moved STEMI ‘Project’ into day to day operation Bimonthly meetings –review of results, outliers, review the flow diagram when changes needed Results still awesome- 80% receive 1 st flow within 90 min of presentation

Changing reperfusion management in the STEMI Population Who receives fibrinolytic therapy? Who receives rescue PCI? What adjuvant therapy is appropriate?

Time is Muscle The longer the clot has matured in the coronary artery, the more difficult it is for a fibrinolytic agent to work. Optimal window - first 3 hours after symptom onset. During this 3-hour window, fibrinolytic therapy and primary PCI have about the same efficacy in terms of limiting mortality.

Time is Muscle Beyond the first 3 hours, primary PCI becomes the preferred strategy because it can salvage myocardium more effectively than fibrinolytic therapy. The goal is to get the patient quickly to where pharmacologic reperfusion is available or to create a situation (system) where the patient can be transported rapidly to a primary PCI center.

Reperfusion Options for STEMI Pts Step One: Assess Time and Risk Time Since Symptoms Time Required to Initiate Invasive Strategy Risk of STEMI Risk of Lysis

PCI FOR AMI STRATEGIES Primary PCI Preferred strategy Rescue PCI Clinical benefit in moderate to large MI Facilitated PCI No proven benefit Likely harmful Immediate PCI Superior to watchful waiting

3. New directions- STEMI project in the Rural Calgary Health Region

Southern Alberta STEMI initiative Early diagnosis of STEMI with field ECG Timely communication between field EMS and local hub /emergency dept Use of technology to transmit ECG Treatment pathway is initiated in the field or local centre Early risk stratification with expedited access to tertiary care for high risk patients Streamline referral process to expedite access to angiography/CV service Rapid patient repatriation

High River STEMI Emergency Department January 15, 2008 (revision due date 3, 6 and 12 months post implementation) MUSE

MUSE (Marquette Universal System for ECG’s) Calgary Health Region’s Electronic ECG Repository

HOW ECG’S ARE TRANSMITTED TO CALGARY HEALTH REGION’S MUSE DATABASE MUSE ECG User with remote access to MUSE WEB can view the ECG “online” ECG’s TRANSMITTED DIRECTLY FROM EMS PROVIDERS IN THE FIELD - URBAN AND RURAL – TOTAL OF 14 EMS PROVIDERS MUSE ECG’s TRANSMITTED FROM CHR RURAL HEALTH CARE FACILITIES (VIA ECG CART OR BEDSIDE MONITOR) – TOTAL OF 14 SITES

Timeliness: ECG acquisition and ability to view it online 01:22 01:27

BENEFITS OF THE HEART ALERT MUSE INITIATIVE Heart Alert’s MUSE initiative affords the Region’s Rural patients Early consultation Improved access to care Access to historical and real time clinical information (ECG transmission)

Pathway Principles Primary Percutaneous Coronary Intervention Eligibility Criteria Onset less than 12 Hours Onset defined as beginning of symptoms leading to patient seeking medical attention

Pathway Principles Onset between 1-3 Hours Primary Percutaneous Coronary Intervention if transport to Catheterization Lab guaranteed within 60 minutes from EDMD Assessment

Pathway Principles Onset 3 – 6 Hours Primary Percutaneous Coronary Intervention Preferred Fibrinolytic Therapy may be recommended by Cardiac Interventionalist if no contraindications or PPCI is delayed

Pathway Principles Onset Hours Primary Percutaneous Coronary Intervention Preferred

Pathway Principles Onset Greater than 12 Hours, continued symptoms, ST Elevation and/or Hemodynamic Instability Contact Cardiac Interventionalist via SARCC regarding plan of care Angiogram with or without Angioplasty

Conclusions System models for Coronary reperfusion are necessary for optimal care in our STEMI population Should we consider the ‘System Approach for STEMI Patients’ as a risk indicator for assessment of AMI programs? Spreading this system model to the rural population is our next challenge. Should it be considered elsewhere?